Tianjin Lisheng Pharmaceutical Co Ltd (002393) — Capital Reinvestment Ratio
Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥287.81 Million) in capital expenditures (CN¥20.11 Million). Check 002393 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Lisheng Pharmaceutical Co Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks Tianjin Lisheng Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. For the full cash flow conversion analysis, see Tianjin Lisheng Pharmaceutical Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2025. See cash generation quality of Tianjin Lisheng Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥451.85 Million | CN¥37.46 Million | ▼ -86.4% |
| 2024 | 0.61x | CN¥88.26 Million | CN¥53.75 Million | ▲ +106.7% |
| 2023 | 0.29x | CN¥209.51 Million | CN¥61.72 Million | ▲ +138.6% |
| 2022 | 0.12x | CN¥331.38 Million | CN¥40.91 Million | ▼ -72.5% |
| 2021 | 0.45x | CN¥196.34 Million | CN¥88.24 Million | ▼ -65.9% |
| 2020 | 1.32x | CN¥76.37 Million | CN¥100.66 Million | ▲ +291.0% |
| 2019 | 0.34x | CN¥268.33 Million | CN¥90.46 Million | ▼ -47.5% |
| 2018 | 0.64x | CN¥162.69 Million | CN¥104.43 Million | ▲ +129.7% |
| 2017 | 0.28x | CN¥179.25 Million | CN¥50.09 Million | ▼ -64.6% |
| 2016 | 0.79x | CN¥173.60 Million | CN¥137.20 Million | ▼ -23.5% |
| 2015 | 1.03x | CN¥198.13 Million | CN¥204.60 Million | ▼ -74.3% |
| 2014 | 4.02x | CN¥72.24 Million | CN¥290.65 Million | ▲ +272.2% |
| 2013 | 1.08x | CN¥289.62 Million | CN¥313.11 Million | ▲ +20.8% |
| 2012 | 0.89x | CN¥250.72 Million | CN¥224.35 Million | ▼ -27.4% |
| 2011 | 1.23x | CN¥134.58 Million | CN¥165.94 Million | ▲ +230.1% |
| 2010 | 0.37x | CN¥186.55 Million | CN¥69.69 Million | ▲ +316.4% |
| 2009 | 0.09x | CN¥196.14 Million | CN¥17.60 Million | ▼ -82.5% |
| 2008 | 0.51x | CN¥126.59 Million | CN¥64.86 Million | ▲ +543.9% |
| 2007 | 0.08x | CN¥174.94 Million | CN¥13.92 Million | — |